RecruitingPhase 4NCT06492512

Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy


Sponsor

Southern Illinois University

Enrollment

120 participants

Start Date

May 27, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called alternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill and a drug called daily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill for people with iron-deficiency anemia (ida) and pregnancy. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGdaily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill

ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill daily

DRUGalternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill

ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill every other day


Locations(1)

Southern Illinois University School of Medicine

Springfield, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06492512


Related Trials